qinlock
(Ripretinib)Deciphera Pharmaceuticals, LLC
Usage: QINLOCK is indicated for adult patients with advanced gastrointestinal stromal tumor (GIST) who have previously been treated with three or more kinase inhibitors, including imatinib.
2 results
romvimza
(Vimseltinib)Deciphera Pharmaceuticals, LLCUsage: ROMVIMZA is indicated for treating adult patients with symptomatic tenosynovial giant cell tumor (TGCT) when surgical resection could worsen functional limitations or lead to severe morbidity.